Figure 3.
Figure 3. Influence of humoral immunity on decreasing viral set points. Patients were stratified according to their ability to improve viremia control upon STI (n = 46). White squares depict patients who decreased viremia by more than 0.5 logs upon STI. Gray squares depict patients who did not reach a 0.5 log improvement of viremia. Horizontal bars indicate mean values. (A) Viral loads before ART and after STI are depicted. Anti-gp120 (B) and anti-p24 (C) titers at baseline (weeks 0 to 2) and maximum increases in titers reached during the trial are shown. Antibody reactivities and viral loads of the individual groups were compared using the unpaired t test. (A-C) All significant observations were significant on the individual level and also after Bonferroni correction.

Influence of humoral immunity on decreasing viral set points. Patients were stratified according to their ability to improve viremia control upon STI (n = 46). White squares depict patients who decreased viremia by more than 0.5 logs upon STI. Gray squares depict patients who did not reach a 0.5 log improvement of viremia. Horizontal bars indicate mean values. (A) Viral loads before ART and after STI are depicted. Anti-gp120 (B) and anti-p24 (C) titers at baseline (weeks 0 to 2) and maximum increases in titers reached during the trial are shown. Antibody reactivities and viral loads of the individual groups were compared using the unpaired t test. (A-C) All significant observations were significant on the individual level and also after Bonferroni correction.

Close Modal

or Create an Account

Close Modal
Close Modal